The role of the clinical pharmacist in the prevention of drug-induced acute kidney injury in the intensive care unit.
Eyup Can PolatAlparslan KocKutay DemirkanPublished in: Journal of clinical pharmacy and therapeutics (2022)
Our findings demonstrate that if a clinical pharmacist is included in the ICU team and provides consultation services to the ICU team regarding patient treatment by performing regular patient follow-up, the incidence of AKI in patients can be minimized and therapeutic outcomes can be improved.
Keyphrases
- drug induced
- liver injury
- palliative care
- intensive care unit
- end stage renal disease
- case report
- newly diagnosed
- healthcare
- ejection fraction
- chronic kidney disease
- acute kidney injury
- prognostic factors
- quality improvement
- mental health
- type diabetes
- metabolic syndrome
- adverse drug
- adipose tissue
- skeletal muscle
- combination therapy
- patient reported outcomes
- patient reported
- insulin resistance